Literature DB >> 15830227

Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory.

Evelin L Schaeffer1, Wagner F Gattaz.   

Abstract

RATIONALE: Phospholipase A(2) (PLA(2)) is a family of enzymes that cleave membrane phospholipids generating important lipid mediators in signal transduction. In rat hippocampal slices, both intracellular cytosolic Ca(2+)-dependent PLA(2) (cPLA(2)) and Ca(2+)-independent PLA(2) (iPLA(2)) have been implicated in mechanisms of synaptic plasticity underlying memory processes. In mice, intraperitoneal injections of a selective iPLA(2) inhibitor impaired spatial learning. Accordingly, reduced cPLA(2) and iPLA(2) activities were found in postmortem hippocampus of patients with Alzheimer's disease.
OBJECTIVE: This study investigates the effects of injections of PLA(2) inhibitors directly into rat hippocampus on the acquisition of short-term (STM) and long-term memory (LTM) of a one-trial step-down inhibitory avoidance (IA) task.
METHODS: Wistar rats were bilaterally implanted with cannulae in the CA1 region of the dorsal hippocampus. After surgery, the rats received bilateral injections of a vehicle, or of dual cPLA(2) and iPLA(2) inhibitors (MAFP or PACOCF(3)), or a selective iPLA(2) inhibitor (bromoenol lactone) before training in IA. The animals were tested 1.5 h (for STM) and 24 h (for LTM) after training.
RESULTS: Significant inhibition of iPLA(2) activity in rat hippocampus impaired acquisition of STM and LTM. Memory impairment did not result from neuronal death after iPLA(2) inhibition. Moreover, IA training per se increased significantly hippocampal PLA(2) activity.
CONCLUSION: The present results suggest a functional effect of hippocampal PLA(2) on the neurochemistry of memory acquisition and support the hypothesis that reduced PLA(2) activity may contribute to memory impairment in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830227     DOI: 10.1007/s00213-005-2256-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  57 in total

Review 1.  Separate mechanisms for short- and long-term memory.

Authors:  I Izquierdo; J H Medina; M R Vianna; L A Izquierdo; D M Barros
Journal:  Behav Brain Res       Date:  1999-08       Impact factor: 3.332

2.  An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde".

Authors:  A Alzheimer; R A Stelzmann; H N Schnitzlein; F R Murtagh
Journal:  Clin Anat       Date:  1995       Impact factor: 2.414

3.  Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats.

Authors:  I Izquierdo; J A Quillfeldt; M S Zanatta; J Quevedo; E Schaeffer; P K Schmitz; J H Medina
Journal:  Eur J Neurosci       Date:  1997-04       Impact factor: 3.386

4.  Increase in arachidonic acid concentration in a postsynaptic membrane fraction following the induction of long-term potentiation in the dentate gyrus.

Authors:  M P Clements; T V Bliss; M A Lynch
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

5.  Rapid and transient learning-associated increase in NMDA NR1 subunit in the rat hippocampus.

Authors:  M Cammarota; M L de Stein; G Paratcha; L R Bevilaqua; I Izquierdo; J H Medina
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

6.  Interactions between arachidonic acid and metabotropic glutamate receptors in the induction of synaptic potentiation in the rat hippocampal slice.

Authors:  D R Collins; R C Smith; S N Davies
Journal:  Eur J Pharmacol       Date:  1995-12-27       Impact factor: 4.432

7.  Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices.

Authors:  S Fujita; Y Ikegaya; M Nishikawa; N Nishiyama; N Matsuki
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

8.  Decreased phospholipase A2 activity in Alzheimer brains.

Authors:  W F Gattaz; A Maras; N J Cairns; R Levy; H Förstl
Journal:  Biol Psychiatry       Date:  1995-01-01       Impact factor: 13.382

9.  Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C.

Authors:  R A Nemenoff; S Winitz; N X Qian; V Van Putten; G L Johnson; L E Heasley
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

Authors:  J W Pettegrew; W E Klunk; K Panchalingam; J N Kanfer; R J McClure
Journal:  Neurobiol Aging       Date:  1995 Jan-Feb       Impact factor: 4.673

View more
  25 in total

1.  Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Authors:  Stefan Smesny; Susan Stein; Ingo Willhardt; Jürgen Lasch; Heinrich Sauer
Journal:  J Neural Transm (Vienna)       Date:  2008-06-27       Impact factor: 3.575

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats.

Authors:  E L Schaeffer; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

4.  Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice.

Authors:  Mireille Basselin; Angelo O Rosa; Epolia Ramadan; Yewon Cheon; Lisa Chang; Mei Chen; Deanna Greenstein; Mary Wohltmann; John Turk; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2010-08-04       Impact factor: 5.922

5.  Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.

Authors:  L L Talib; S R Hototian; H P G Joaquim; O V Forlenza; W F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-04-29       Impact factor: 5.270

6.  Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue.

Authors:  Marco A S Gama; Nádia R B Raposo; Fábio B Mury; Fernando C F Lopes; Emmanuel Dias-Neto; Leda L Talib; Wagner F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2015-04-26       Impact factor: 3.575

Review 7.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

Review 8.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

9.  Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats.

Authors:  E L Schaeffer; L Zorrón Pu; D A M Gagliotti; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

10.  Calcium-independent phospholipase A2 mediates store-operated calcium entry in rat cerebellar granule cells.

Authors:  Karthika Singaravelu; Christian Lohr; Joachim W Deitmer
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.